Tela Bio Executives Stack Shares and Options Ahead of 2027 RSU Vesting, Betting Big on Future Breakthroughs
CEO’s 176k‑share RSU grant and insider option spikes reveal management confidence in Tela Bio’s biotech pipeline—watch vesting dates for potential upside.
4 minutes to read